Introduction: Despite the technical and scientific progress that improved therapeutic resources available in Oncology, adverse effects of treatment can be prominent, impacting the quality of life (QoL). Objective: This research aims to determine the prevalence of post-radiotherapy pelvic symptoms in prostate cancer (PC) and its impact on QoL. Methods: We assessed three groups of patients at different stages during radiotherapy (RT): Pre-RT, evaluated before of RT; Post-RT#1, evaluated between six months and one year post-RT; Post-RT#2, evaluated between two and a half and four years post-RT. The presence of urinary incontinence (UI), its characteristics and impact on daily living activities (DLA) were evaluated by ICIQ-SF questionnaire. WHOQOL-BREF questionnaire was used to assess QoL. Student t test was used, considering significant p < 0.05. Results: Thirty-three men were assessed (pre-RT, n = 12; Post-RT#1, n = 10; Post-RT#2, n = 11). The prevalence of lower urinary tract symptoms (LUTS) was highest in Post-RT#1 group. Post-RT#2 group had the highest * RAM: Doctoral student, e-mail: alinemrib@gmail. prevalence of post-RT UI. In QoL, Pre-RT and Post-RT#2 groups experiencing the greatest impact on physical, environmental and overall QoL. Conclusion: Acute effect of RT is characterized by a high prevalence of LUTS. Post-RT#2 group experienced the most adverse effects on DLA due to a higher prevalence of post-RT UI. n = 12; n = 10; n = 11 
Introduction
Cancer has transformed its original characteristic of disease prevalent in developed countries. In the last four decades, it has become a global public health problem, especially among developing countries, where it is expected that in the coming decades the impact of cancer on the population will account for 80% of the estimated 20 million new cases by 2025 [1] .
In Brazil, preliminary data for 2016 indicates the occurrence of about 596,070 new cases of cancer. Prostate cancer (PC) is one of the most prevalent cancers in men, excluding nonmelanoma skin tumor, with an incidence estimated in 61,200 new cases [1] .
D' Amico et al. [2] estimated the risk of biochemical recurrence in localized CaP using serum levels of prostatic specific antigen (PSA) and Gleason score levels, a histopathological analysis of the fragments collected in the biopsy. Three risk classes were defined as low (PSA ≤ 10ng / mL and Gleason score ≤ 6), intermediate (PSA > 10 and ≤ 20ng / mL and Gleason score 7) and high (PSA > 20ng / mL and Gleason score ≥ 8).
As a basic rule, considering the patient's life expectancy in low-risk PC, the therapeutic possibilities are active surveillance, radical prostatectomy (PR) and RT or brachytherapy (BQT) [3] . At intermediate risk, hormone therapy (HT) combined with RT, BQT or PR are acceptable therapeutic options. In the treatment of high-risk cancer, the best treatment options are the combination of HT and RT, or PR followed by RT [4] . Data from Surveillance, Epidemiology and End Results (SEER) showed that, in general, 33 .9% of patients were submitted to conservative treatment, 29.6% underwent PR and 36.5% underwent RT [5] .
Radiotherapy (RT) has been shown to improve local control and biochemical recurrence-free survival. It is critical in the treatment of prostate cancer (PC). However, some adverse effects to radiation are expected. The most common complications from the various RT treatments include urinary, anorectal, and Fisioter Mov. 2017;30(Suppl 1):S197-208 sexual dysfunction. These side effects are attributed to acute and chronic radiation injuries to the rectum, bladder, and other pelvic organs. These present not only as mucositis, but also as functional disorders, erectile activity, bladder or rectal continence, direct injury to the sphincter, or radiation neuritis involving the sacral plexus and nerves [6 -8] .
Acute side effects of RT are usually short-term and treatable with medication but late complications can lead to damage that is difficult to reverse, impairing the quality of life (QoL). In addition to the physiological repercussions, post-RT pelvic symptoms may restrict daily living activities (DLA), social interactions, and self-perception of health. The greatest problems are related to social and mental well-being, which may have psychological, physical, professional, social, and sexual repercussions with a significant impact on QoL [9, 10] .
The hypothesis of this study was that men receiving RT for PC have a high prevalence of lower urinary tract symptoms (LUTS), anorectal, and sexual complaints compared to men who did not receive RT. The longer the time after RT, the higher the prevalence of these pelvic symptoms and lower the QoL. The aim of this study was, therefore, to determine the prevalence of pelvic symptoms post-RT in PC patients and the impact on QoL.
Methods

Design of the study
Cross-sectional study.
Context
Volunteer recruitment and data collection were performed at the Clinical Hospital of the Medical School of Ribeirão Preto, University of São Paulo (HCFMRP-USP) from August to October 2013.
Subjects
Volunteer recruitment was conducted through a survey of all patients referred to the Radiotherapy Division of HCFMRP-USP for PC treatment by a temporal sequence of aftercare service. Men over the age of 45 years with a diagnosis of PC confirmed by clinical examination and biopsy, and assigned to RT were evaluated for the study. We excluded men with anatomical alterations in the perineal region due to sequelae of surgery, disease, trauma, or local lesions; associated neurological diseases; incomplete RT regimen; or those who had previously undergone of the pelvic floor muscles training (PFMT) or another treatment for the management of pelvic symptoms.
Study groups
Volunteer recruitment was based on the periods set for the study, in which the patients were divided into three groups: a) Pre-RT group: patients with indication for RT, non-treated, evaluated before starting treatment; b) Post-RT #1 group: patients treated, with a period of six months and one year post-RT; c) Post-RT #2 group: patients treated, with a period of two and a half and four years post-RT;
Sample Size
A convenience sample was used for this study.
Variables
This study evaluated men diagnosed with PC with a recommendation for treatment by RT alone or concomitant with other cancer treatments, namely radical prostatectomy (RP) and hormone therapy (HT). Regardless of the group assigned, each volunteer was subjected to the same tests performed by the same physiotherapist.
Evaluation of urinary, anorectal, and sexual complaints
The volunteer's medical history and sociodemographic and personal data, as comorbidities, age, weight, height, scholarity, colour, marital status and health habits, were obtained. Urological, anorectal, and sexual history were obtained through the medical records analysis and confirmed with the volunteers during the interview.
Evaluation of the state of urinary continence and impact of incontinence on daily living activities
The International Consultation on Incontinence Questionnaire -Short Form (ICIQ-SF) in Portuguese was used to evaluate the patient's urinary continence and impact of urinary incontinence (UI) on DLA. This questionnaire was translated into Portuguese and validated for both sexes [11] .
Assessment of quality of life
The patient also answered a questionnaire to assess QoL, the World Health Organization Quality of Life -Brief (WHOQOL-BREF) [12] .
Statistical analysis
For analysis between groups, we used the Student t test, considered statistically significant at p < 0.05.
Ethical aspects
This research was referred to and approved by the Research Ethics Committee of HCFMRP-USP (HCRP n° 3014/2013).
Results
Subjects
Of the 69 patients enrolled in the study, only 33 were included (Figure 1 ).
Descriptive data
The sociodemographic and personal data are in the Table 1 . There were no significant differences in age and body mass index (BMI) between the groups (p = 0.4). 
Marital status
Single Information related to cancer and cancer treatment are summarized in Table 2 . Table 3 below summarizes information regarding pre and post-RT pelvic symptoms. The term "irritative" included complaints of the urgency to urinate and increased daytime urinary frequency. 
Anorectal complaints
Anal pain
AI and fecal urgency 0 (0) - The evaluation of UI and its impact on DLA was measured by the ICIQ-SF, in accordance with the questions analyzed by the questionnaire, are presented below (Table 4 ). There was no significant difference in the ICIQ score between groups. 
Quality of life
In a QoL analysis as assessed by the WHOQOL-BREF (Table 5) , there was a significant difference in the questionnaire scores between the Pre-RT and Post-RT #1 groups and Post-RT #1 and Post-RT #2 groups in physical, environmental and overall QoL. 
Discussion
Among the different treatment modalities for PC, RT has been noteworthy because of its importance in the local control of disease and comparatively fewer side-effects [13] . However, despite advances that allows modulation of the radiation intensity to allow maximum preservation of healthy organs, some areas, such as the bladder and rectum, are particular sensitive and can tolerate small doses of radiation, leading to varying degrees of toxicity.
Ghadjar and collaborators [14] studied the acute and late effects of RT in 39 men with PC. Grade 2 gastrointestinal toxicity (particularly diarrhea, pain, and rectal bleeding) varied from 3% to 8% of cases. No patients had Grade 3 toxicity. In the follow-up period (total of two years), Grade 2 toxicity was found to decrease with time, reaching 0% by the end of the follow-up period. These data corroborate our study, where we observed that gastrointestinal and anorectal complaints were uncommon.
The same study also showed that 56% of patients had Grade 2 genitourinary toxicity (dysuria, UI, urinary retention, increased urinary frequency/ urgency, and hematuria). This dropped to 28% later in the follow-up period. There were no cases of Grade 4 genitourinary toxicity [14] . In our study, irritative symptoms (urinary urgency and daytime frequency) and nocturia, when considered together, were more frequent in the Post-RT #1 group. However, a decrease in these symptoms was not widely observed in the Post-RT #2 group. This can be explained by the higher number of incontinent patients in the Post-RT #2 group (45.5%, n=5), who tend to have a greater prevalence of urge urinary incontinence (UUI) (n=4). Symptoms such as urinary urgency, increased urinary frequency and nocturia are characteristic of UUI. Other study [10] also found that late side effects can be particularly more relevant in chronic lesions in adjacent tissues.
Erectile dysfunction (ED) was another prevalent complaint in the study. The ED rates found here corroborate the findings of two prospective studies, which showed a 30-40% incidence of ED in patients between one and two years post-RT [15, 16] .
The use of specific questionnaires for evaluation of symptoms is important in defining the type of complaint, and its severity and impact on DLA and QoL. Compared to women, the number of specific questionnaires for urinary complaints validated in Portuguese for men is low. The ICIQ-SF is a questionnaire validated for both sexes in the Brazilian population [11] . Other studies have also utilized the same questionnaire in men [17 -19] . A Brazilian study [20] recently analyzed the correlation between the ICIQ-SF and urodynamic findings in men with UI after RP, representing the first study to address this correlation in men. Despite the correlations found in women, the total ICIQ-SF score could not differentiate whether sphincter incontinence or bladder dysfunction was the main cause of UI in that study. This finding confirms the hypothesis that it is not possible to determine the main cause of post-RP UI based on subjective assessment alone. The authors suggest, therefore, that the ICIQ-SF was designed to generally assess UI symptoms, LUTS and its impact on the QoL of men and women [20] . This was the purpose of our study, where ICIQ-SF was chosen as an easily applied and understood questionnaire to assess the presence, severity and impact of urinary loss in DLA.
The efficacy of a particular type of cancer treatment is assessed by biomedical parameters such as tumor shrinkage, progression-free survival, overall survival, and toxicity. However, these results also need to be measured in terms of outcome of functionality of the patient and their psychological health. Hence, there is a need to establish the impact of the disease and its treatment on the QoL. A prospective cohort study evaluated the QoL of men with PC who underwent RP or RT. Starting with the pre-treatment and a follow-up examination up to five years afterward, 704 patients with localized PC (low or intermediate risk) were recruited between 2003 and 2005 by Ferrer and collaborators [10] . QoL was assessed by the Expanded Prostate Cancer Index Composite (EPIC) questionnaire. Results showed that the impact of brachytherapy on QoL was restricted to the urinary complaints without intestinal complaints or adverse sexual effects. Initially, the impact of UI was minor but increased over the five years post-RT and the impact of the irritative and obstructive symptoms was moderate throughout the entire follow-up period, similar data that we found in our study. Function worsened slightly over time after RT.
Other study [21] also reinforces our findings in the QoL assessment. The study explored the longterm impact of acute and/or late RT symptoms on QoL. The study monitored 298 patients prospectively in four distinct periods: (A) before RT; (B) at the last RT session; (C) two months after RT; and (D) one year after RT. Evaluation was performed using the EPIC questionnaire. Correlation and sub-group analysis showed a strong relationship between urinary and bowel symptoms before and after RT. In contrast, the absolute scores did not have the same correlation. Long-term changes can be predicted by post-RT acute alterations. That is, patients reporting urinary and bowel problems ranging from major to moderate during timeframe C had great to moderate inconvenience due to the same complaints in ≥ 50% of these patients during D. In addition, changes in QoL scores during B were independently predictive of poorer longterm QoL, despite the different QoL assessment tools used here compared to the study above [21] . Our results reinforce the same conclusions of the Pinkawa et al: patients who had no improvement in acute toxicity were candidates for a closer followup examination to identify possible preventive actions that could reduce the high probability of long-term problems.
Various treatment modalities are available to manage UI, including pharmacological therapy, behavioral therapy and surgical treatment. In 1948, Kegel first advocated PFMT to enhance urethral resistance and promote urinary control [22] . The application of Kegel exercises has been broadened to various applications but the concentration continues to be for UI secondary to sphincteric deficiency. Many studies have shown that the success of PFMT for IU depends on the degree and duration of treatment, and close supervision by a physical therapist.
Therefore, Physical Therapy is a therapeutic option without side effects and lower cost. It may contribute to improvement of pelvic complaints and symptoms and consequent improvement in QoL.
PFMT is a first-line treatment used to restore pelvic floor or bladder function. PFMT trains subjects to isolate and correctly contract the pelvic floor muscles (PFM) to increase strength and endurance. Repeated contractions are thought to improve urinary control through increased support for the detrusor muscle and urethral sphincter [23] .
However, the benefit of PFMT and reeducation for male UI has not been well studied. Most studies focus on the PFMT in men undergoing RP showing promising results [24 -26] . But, patients undergoing RT are not studied. Additional trials are needed to confirm the effectiveness of this conservative treatment option in the patients treated with RT.
Limitations
Among the limitations of our study, first is the inclusion of men who were prostatectomized and submitted to HT.
RP is one of the most frequently used alternative therapies for PC. Although it has a high cure rate, surgery is often followed by complications, with UI and ED the most important. From our prostatectomized sample population (n = 8), five patients complained of UI, though two had UI prior to RT. The most important cause of UI in adult males was a sphincter injury due to prostate surgery to reduce bladder urethral junction to maintain urinary continence, creating greater demands of the PFM [27] . The overall prevalence of UI after RP ranges from 2% to 60%, although rates decrease with time [28] . Bladder dysfunctions may be present in these cases. However, the prevalence of UI post-RP is higher due to sphincter deficiency (88%) and lower due to bladder dysfunction [29, 30] , according to the urodynamic findings. These observations are confirmed by our study, as characterization of UI in post-RP patients is associated with effort UI.
From our sample of prostatectomized patients, seven complained of pre-RT ED (87.6%). ED post-RP is multifactorial, though the main cause is of neurogenic origin due to the cavernous nerve lesion during the dissection of the cavernous neurovascular bundle. ED can also have a psychogenic and/or vasculogenic origin. Post-RP ED rates range from 10-90% [31] , as seen in the present study.
Little data is available on the effect of HT on the lower urinary tract. A research [32] studied the possible association between the severity of LUTS and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. They concluded that severity of urinary symptoms is associated with age and testosterone serum levels. However, age was the only predisposing factor for prostate volume in the statistical analysis. Testosterone itself may not be the main driver of the effects on urinary tract structures that are anatomically and functionally related to LUTS [32] . However, other studies have showed that the androgen receptors are present in most of epithelial cells of the urethra and bladder [33] and discussed the role of testosterone and its metabolites in maintaining pelvic reflex activity of the autonomic nervous system in rats [34] . Additional large studies are required to confirm these preliminary results in humans [32] .
Men who receive HT also report lower sexual activity, fewer sexual thoughts, and fewer spontaneous erections than men with normal testosterone levels [35] . This may explain the number of patients with ED in the pre-RT group.
Another factor would be the age and obesity. Age is the main risk factor for PC. Obesity also presents as an important risk factor for the development of cancer [1] . Both factors may also have some influence on LUTS. UI is not a normal part of aging, but age-related conditions and changes in bladder function and PFM can contribute to loss of sphincter control in the elderly. However, elderly are more prone to other factors associated with UI: comorbidities, polypharmacy, functional limitations, cognitive impairment, and prostate diseases [36, 37] .
Although the included patients were mostly elderly, our sample was composed of men with good cognitive status, without functional limitations and important comorbidities. The sample also did not present relevant LUTS relative to the age before RT. Thus, we believe that age is not a confounding factor for the data analyzed in this study. In relation to obesity, the increase in bladder pressure due to obesity would in turn increase afferent stimuli, leading to increased urinary urgency and frequency. However, men have higher fixation of the PFM and are, therefore, less susceptible to these forces, which prevents symptoms of increasing weight until a certain set point or significant obesity is reached [38] . On average, our sample was not composed of obese men with a BMI above 30 kg/m 2 , but men with overweight.
Other limitations of this study include the short period of time used to develop a longitudinal study. We were not able to monitor the same patients before and after RT. However, the lack of studies in this field allowed us to survey the characteristics of these patients and trace the treatment outcomes for future research. Future investigations would involve identifying conservative approaches for symptom management leading to QoL improvement, especially in patients already presenting with pelvic symptoms before RT.
However, despite the limitations, our main motivation with this research was to outline the scenario in which these patients are inserted, analyzing its context and thereby stimulate a more comprehensive investigation of the matter. Understanding the pelvic symptoms more prevalent after RT in the PC treatment may help to understand the impact of treatment on patients and to stimulate the search for strategies to prevent or minimize these complaints with consequent improvement in QoL and the patient functionality.
Conclusion
The acute effect of RT was characterized by a higher prevalence of LUTS (especially urinary urgency and nocturia). The Post-RT #2 group showed greater impact on DLA due to the higher prevalence of post-RT UI and poorer QoL scores compared to recently irradiated patients.
